Cleared Special

K132259 - BD VERITOR SYSTEM FOR THE RAPID DETECTION OF FLU A+B (FDA 510(k) Clearance)

Aug 2013
Decision
19d
Days
Class 2
Risk

K132259 is an FDA 510(k) clearance for the BD VERITOR SYSTEM FOR THE RAPID DETECTION OF FLU A+B. This device is classified as a Devices Detecting Influenza A, B, And C Virus Antigens (Class II - Special Controls, product code PSZ).

Submitted by Becton, Dickinson and Company (San Diego, US). The FDA issued a Cleared decision on August 7, 2013, 19 days after receiving the submission on July 19, 2013.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3328. An Influenza Virus Antigen Detection Test System Is A Device Intended For The Qualitative Detection Of Influenza Viral Antigens Directly From Clinical Specimens In Patients With Signs And Symptoms Of Respiratory Infection..

Submission Details

510(k) Number K132259 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 19, 2013
Decision Date August 07, 2013
Days to Decision 19 days
Submission Type Special
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code PSZ — Devices Detecting Influenza A, B, And C Virus Antigens
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.3328
Definition An Influenza Virus Antigen Detection Test System Is A Device Intended For The Qualitative Detection Of Influenza Viral Antigens Directly From Clinical Specimens In Patients With Signs And Symptoms Of Respiratory Infection.